Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-30 01:12:52 - browse：8992

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Study says nonprofit hospitals fall short in charity care spending

WSS

Patient advocates debate FDA's accelerated approval process

Supreme Court mifepristone arguments center on docs' right to sue

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

A virus, fished out of a lake, may have saved a man’s life

Abortion pill Supreme Court ruling could impact entire drug industry

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Cancer drug shortages should be causing more outrage

What to expect at HLTH 2023, the health care industry conference

Activists slam private health insurers over coverage restrictions

FDA authorizes Novavax’s updated Covid

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Medicare details structure of new drug price negotiation program

Study says nonprofit hospitals fall short in charity care spending

Guidelines to prevent youth baseball injuries need more muscle

Decaf coffee targeted by food safety group under obscure FDA rule

hotspot

Oprah kicked off a national conversation on obesity. Let's have it

FDA panel signals lack of confidence in Amgen cancer drug data

Readout Newsletter: Merck, Vertex, and Viking updates

A virus, fished out of a lake, may have saved a man’s life

Will generative AI in health care meet the fate of IBM's Dr. Watson?

When women are denied an abortion, their children fare worse than peers

hotspot

hotspot

knowledge

entertainment